Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is considered a very rare disease. With C3G, patients have issues with their immune system that cause kidney damage and symptoms ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

Medically reviewed by David Hampton, MD C3G is caused by immune system dysfunction that can lead to kidney issues.When the kidneys don't work as they should, people can experience blood or protein in ...

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...

Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...

This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...

A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

OpenAI just released a report about healthcare drawn from anonymized chatbot conversations. The title could double as one of ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Neuroimmune diseases, such as multiple sclerosis, myasthenia gravis, and autoimmune encephalitis, are debilitating conditions ...